Please login to the form below

Not currently logged in
Email:
Password:

Peter Goold and Colin White join Penn Pharma

Appointed to senior roles in supply chain team

Colin White - Penn PharmaPenn Pharma has appointed Peter Goold and Colin White (pictured) to senior positions in its supply chain team.

Peter Goold will take over the newly created role of director of supply chain and project management at the UK-based pharma services company, while Colin White has been appointed as head of manufacturing, running the production operation at Penn's UK facility.

Penn's chief executive, Dr Richard Yarwood said: “Peter and Colin join Penn at an integral point in the company's growth. Their strong technical backgrounds in their respective areas and vast customer service experience in outsourcing will be a great asset to the Penn brand.”

This growth includes the construction of new facilities due to open in 2013 that will boost the company's manufacturing efforts.

According to Penn, Goold and White have a combined 30 years of experience in the pharmaceutical and outsourcing industry, which has included running global supply chain operations covering commercial packing, solid oral dose manufacturing, and sterile products production.

Goold said: “It is fantastic to be joining Penn at such a momentous stage in the company's growth. The growth plans in place are a great motivation to ensure additional business is secured for our new contained manufacturing operation.”

22nd June 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
S&H Medical Communications

S&H Medical Communications has a reputation for excellence, insight and energy. The collaborative team, from diverse backgrounds and supported by...

Latest intelligence

14_ipad_lowres.jpg
Do your customers feel that you’re listening to them?
When answering to data, excellent digital communication can create much stronger relationships between reps and customers....
Mapping content strategies to pharma lifecycle management
In these tough economic times, we should be ramping up our pharma lifecycle management (LCM) strategies. These are well-established strategies for managing and extending the commercial value of products. So...
Back from the future – innovation for pharma
After 5 days of seeing amazing innovations, having discussions about the future of medicine and the practicalities of living on Mars. Plus listening to inspiring speakers from fighter plane-flying physicians...

Infographics